4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
BioLineRx Ltd. (BLRX) operates in the Biotechnology industry and is headquartered in Hevel Modi'in, Israel with about 20 employees. Its market capitalization is roughly $10 million. In the fiscal year ended 2025-12-31, BLRX reported $1M in revenue and ($1M) in net income.
BioLineRx Ltd., a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases.
Interactive charts & full statements → Open the BLRX valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $1M | $1M | $29M | $5M | $0M |
| Gross Profit | $1M | $1M | $20M | $1M | $0M |
| Operating Income (EBIT) | ($12M) | ($10M) | ($20M) | ($50M) | ($29M) |
| Net Income | ($7M) | ($1M) | ($9M) | ($61M) | ($25M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Gross Profit | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($4M) | ($3M) | ($3M) | ($2M) | ($2M) | — |
| Net Income | ($3M) | ($2M) | ($1M) | ($1M) | ($4M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $41M | $39M | $64M | $76M | — |
| Total Liabilities | $18M | $25M | $51M | $26M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BLRX viewer.
This page in other languages: עברית
About TickerBase · Data methodology & sources · Privacy · Terms